Dr. Stephen Freedland is Director of the Center for Integrated Research in Cancer and Lifestyle, Co-Director of the Cancer Genetics and Prevention Program, and Associate Director for Faculty Development at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai. He is also a faculty physician in the Division of Urology at the Cedars-Sinai Department of Surgery.
Freedland’s clinical expertise focuses on urological diseases, particularly benign prostatic hyperplasia and prostate cancer. His approach toward cancer prevention and awareness focuses on treating the whole patient, not just the disease, by combining traditional Western medicine with complementary holistic interventions. His research interests include urological diseases and the role of diet, lifestyle and obesity in prostate cancer development and progression, as well as prostate cancer among racial groups and risk stratification for men with prostate cancer.